http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103417968-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103417968-B |
titleOfInvention | Poly-cytimidine is the purposes in preparation treatment human glioma's medicine in conjunction with albumen 2 inhibitor |
abstract | The present invention relates to poly-cytimidine in conjunction with albumen 2 inhibitor the purposes in preparation treatment human glioma's medicine. Particularly, the present invention finds that poly-cytimidine is in conjunction with albumen 2(PCBP2 first) high expressed finding suppresses PCBP2 in human glioma function can suppress the growth of neuroglial cytoma and promote the apoptosis of neuroglial cytoma. The present invention's gliomatous treatment of behaving provides new medicine. |
priorityDate | 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.